Thermo Fisher Scientific Inc (TMO) Shares Sold by Pillar Pacific Capital Management LLC

Pillar Pacific Capital Management LLC trimmed its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,245 shares of the medical research company’s stock after selling 485 shares during the quarter. Thermo Fisher Scientific makes up 1.4% of Pillar Pacific Capital Management LLC’s investment portfolio, making the stock its 5th largest position. Pillar Pacific Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $11,020,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of TMO. BlackRock Inc. grew its position in shares of Thermo Fisher Scientific by 2,692.1% in the 1st quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock valued at $3,531,095,000 after buying an additional 22,165,530 shares during the last quarter. Capital Research Global Investors grew its position in shares of Thermo Fisher Scientific by 29.8% in the 2nd quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after buying an additional 3,973,136 shares during the last quarter. Janus Henderson Group PLC grew its position in shares of Thermo Fisher Scientific by 2,058.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,342,046 shares of the medical research company’s stock valued at $408,620,000 after buying an additional 2,233,522 shares during the last quarter. Veritas Asset Management LLP grew its position in shares of Thermo Fisher Scientific by 112.4% in the 2nd quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock valued at $424,095,000 after buying an additional 1,286,259 shares during the last quarter. Finally, Harbour Capital Advisors LLC grew its position in shares of Thermo Fisher Scientific by 18,197.5% in the 2nd quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock valued at $6,884,000 after buying an additional 1,194,487 shares during the last quarter. 85.32% of the stock is currently owned by hedge funds and other institutional investors.

In related news, VP Seth H. Hoogasian sold 4,140 shares of the firm’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $177.80, for a total value of $736,092.00. Following the completion of the sale, the vice president now owns 25,518 shares in the company, valued at $4,537,100.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director C Martin Harris sold 360 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The disclosure for this sale can be found here. Insiders sold 60,420 shares of company stock valued at $11,308,477 in the last quarter. Company insiders own 0.49% of the company’s stock.

Several research analysts have issued reports on TMO shares. Cowen and Company reissued an “outperform” rating and set a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Leerink Swann raised their price objective on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. Goldman Sachs Group, Inc. (The) started coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 price objective on the stock. Finally, Deutsche Bank AG set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $205.71.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) opened at $192.75 on Thursday. The firm has a market cap of $77,364.04, a PE ratio of 21.20, a PEG ratio of 1.77 and a beta of 1.08. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc has a fifty-two week low of $139.07 and a fifty-two week high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.03 earnings per share. sell-side analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.19%.

WARNING: “Thermo Fisher Scientific Inc (TMO) Shares Sold by Pillar Pacific Capital Management LLC” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://sportsperspectives.com/2017/11/23/thermo-fisher-scientific-inc-tmo-shares-sold-by-pillar-pacific-capital-management-llc.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply